Identification of potential mediators of the relationship between body mass index and colorectal cancer: a Mendelian randomization analysis
Emmanouil Bouras,Dipender Gill,Verena Zuber,Neil Murphy,Niki Dimou,Krasimira Aleksandrova,Sarah J Lewis,Richard M Martin,James Yarmolinsky,Demetrius Albanes,Hermann Brenner,Sergi Castellví-Bel,Andrew T Chan,Iona Cheng,Stephen Gruber,Bethany Van Guelpen,Christopher I Li,Loic Le Marchand,Polly A Newcomb,Shuji Ogino,Andrew Pellatt,Stephanie L Schmit,Alicja Wolk,Anna H Wu,Ulrike Peters,Marc J Gunter,Konstantinos K Tsilidis
DOI: https://doi.org/10.1093/ije/dyae067
2024-04-11
Abstract:Background: Colorectal cancer (CRC) is the third-most-common cancer worldwide and its rates are increasing. Elevated body mass index (BMI) is an established risk factor for CRC, although the molecular mechanisms behind this association remain unclear. Using the Mendelian randomization (MR) framework, we aimed to investigate the mediating effects of putative biomarkers and other CRC risk factors in the association between BMI and CRC. Methods: We selected as mediators biomarkers of established cancer-related mechanisms and other CRC risk factors for which a plausible association with obesity exists, such as inflammatory biomarkers, glucose homeostasis traits, lipids, adipokines, insulin-like growth factor 1 (IGF1), sex hormones, 25-hydroxy-vitamin D, smoking, physical activity (PA) and alcohol consumption. We used inverse-variance weighted MR in the main univariable analyses and performed sensitivity analyses (weighted-median, MR-Egger, Contamination Mixture). We used multivariable MR for the mediation analyses. Results: Genetically predicted BMI was positively associated with CRC risk [odds ratio per SD (5 kg/m2) = 1.17, 95% CI: 1.08-1.24, P-value = 1.4 × 10-5] and robustly associated with nearly all potential mediators. Genetically predicted IGF1, fasting insulin, low-density lipoprotein cholesterol, smoking, PA and alcohol were associated with CRC risk. Evidence for attenuation was found for IGF1 [explained 7% (95% CI: 2-13%) of the association], smoking (31%, 4-57%) and PA (7%, 2-11%). There was little evidence for pleiotropy, although smoking was bidirectionally associated with BMI and instruments were weak for PA. Conclusions: The effect of BMI on CRC risk is possibly partly mediated through plasma IGF1, whereas the attenuation of the BMI-CRC association by smoking and PA may reflect confounding and shared underlying mechanisms rather than mediation.